Unique ID issued by UMIN | UMIN000008898 |
---|---|
Receipt number | R000010255 |
Scientific Title | A comparison of fosaprepitant and droperidol for prevention of postoperative nausea and vomiting in patients undergoing craniotomy: a randomized double-blinded study |
Date of disclosure of the study information | 2012/09/12 |
Last modified on | 2015/09/27 10:37:42 |
A comparison of fosaprepitant and droperidol for prevention of postoperative nausea and vomiting in patients undergoing craniotomy: a randomized double-blinded study
Intraoperative Fosaprepitant for Craniotomy Trial (IFOSAC trial)
A comparison of fosaprepitant and droperidol for prevention of postoperative nausea and vomiting in patients undergoing craniotomy: a randomized double-blinded study
Intraoperative Fosaprepitant for Craniotomy Trial (IFOSAC trial)
Japan |
craniotomy
Anesthesiology |
Others
NO
Fosaprepitant is highly effective for prevention of nausea and vomiting and is used in Japan only in chemotherapy. In this randomized double-blinded study, we aimed to clarify the efficacy of fosaprepitant for prevention of postoperative nausea and vomiting (PONV) in craniotomy, using droperidol as a control drug.
Efficacy
Postoperative accumulative incidence of PONV within 72 hours after surgery
Interventional
Parallel
Randomized
Double blind -all involved are blinded
Active
2
Treatment
Medicine |
Fosaprepitant group (group F) : drug 1 (= fosaprepitant 150mg + saline 100ml) and dexamethason 10mg is intravenously administered after induction of anesthesia and drug 2 (saline 2ml) is intravenously administered 30 minutes before end of surgery.
Droperidol group (group D) : drug 1 (= saline 100ml) and dexamethason 10mg is intravenously administered after induction of anesthesia and drug 2 (droperidol 0.625mg/0.25ml + saline1.75ml) is intravenously administered 30 minutes before end of surgery.
20 | years-old | <= |
80 | years-old | > |
Male and Female
Patients from 20 years old to 80 years old undergoing craniotomy
1. high risk patient (ASA risk 4 and above)
2. patient with low level of consciousness (Japan Coma Scale 2 and above)
Patient with preoperative lowered consciousness is excluded before registration and patient with postoperative lowered consciousness is excluded when it is detected. Patient who exits from operating room with tracheal intubation is also excluded from analysis.
3. patient with nausea or vomiting before surgery
4. antiemetic-taken patient within 24 hours before surgery
5. patient with motions disease
6. patient with highly impaired liver function and renal function
7. patient with morbid obesity (BMI more than 35)
8. patient with allergy to fosaprepitant, aprepitant, droperidol, dexamethasone, propofol, or rocronium
9. patient with cognitive dysfunction
200
1st name | |
Middle name | |
Last name | Masahiko Kawaguchi |
Nara medical university
Department of anesthesiology
840, Shijo-cho, Kashihara, Nara
0744-22-3051
drjkawa@gmail.com
1st name | |
Middle name | |
Last name | Jun Atsuta |
Nara medical university
Department of anesthesiology
840, Shijo-cho, Kashihara, Nara
0744-22-3051
atsutajun@gmail.com
Department of anesthesiology, Nara medical university
none
Self funding
NO
2012 | Year | 09 | Month | 12 | Day |
Unpublished
Completed
2012 | Year | 09 | Month | 01 | Day |
2012 | Year | 09 | Month | 12 | Day |
2015 | Year | 04 | Month | 30 | Day |
2015 | Year | 06 | Month | 30 | Day |
2015 | Year | 07 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2012 | Year | 09 | Month | 11 | Day |
2015 | Year | 09 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010255
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |